- Home
- PHAT vs SSRM Comparison
PHAT vs SSRM Comparison
Compare PHAT & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- SSRM
- Stock Information
- Founded
- PHAT 2018
- SSRM 1946
- Country
- PHAT United States
- SSRM United States
- Employees
- PHAT N/A
- SSRM N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- SSRM Precious Metals
- Sector
- PHAT Health Care
- SSRM Industrials
- Exchange
- PHAT Nasdaq
- SSRM Nasdaq
- Market Cap
- PHAT 1.2B
- SSRM 971.1M
- IPO Year
- PHAT 2019
- SSRM 1996
- Fundamental
- Price
- PHAT $8.78
- SSRM $5.51
- Analyst Decision
- PHAT Strong Buy
- SSRM Hold
- Analyst Count
- PHAT 4
- SSRM 4
- Target Price
- PHAT $22.50
- SSRM $7.01
- AVG Volume (30 Days)
- PHAT 1.9M
- SSRM 2.7M
- Earning Date
- PHAT 11-07-2024
- SSRM 11-06-2024
- Dividend Yield
- PHAT N/A
- SSRM 5.08%
- EPS Growth
- PHAT N/A
- SSRM N/A
- EPS
- PHAT N/A
- SSRM N/A
- Revenue
- PHAT $26,270,000.00
- SSRM $1,098,328,000.00
- Revenue This Year
- PHAT $6,714.96
- SSRM N/A
- Revenue Next Year
- PHAT $293.69
- SSRM $3.42
- P/E Ratio
- PHAT N/A
- SSRM N/A
- Revenue Growth
- PHAT N/A
- SSRM N/A
- 52 Week Low
- PHAT $6.07
- SSRM $3.76
- 52 Week High
- PHAT $19.71
- SSRM $12.04
- Technical
- Relative Strength Index (RSI)
- PHAT 23.73
- SSRM 43.03
- Support Level
- PHAT $8.91
- SSRM $5.26
- Resistance Level
- PHAT $19.05
- SSRM $6.60
- Average True Range (ATR)
- PHAT 1.74
- SSRM 0.30
- MACD
- PHAT -1.05
- SSRM -0.09
- Stochastic Oscillator
- PHAT 2.19
- SSRM 29.22
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.